Rubric Capital Management (New York)’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Rubric Capital Management (New York)’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-716,473	Closed	-$9.82M	–	67
2019 Q3	$9.82M	Buy	716,473 +100,000	+16%	+$1.19M	0.9%	33
2019 Q2	$7.58M	Sell	616,473 -101,834	-14%	-$1.17M	0.6%	38
2019 Q1	$8.96M	Hold	718,307	–	–	0.84%	40
2018 Q4	$8.13M	Sell	718,307 -1,406,693	-66%	-$22.1M	1.01%	30
2018 Q3	$39.8M	Buy	2,125,000 +151,286	+8%	+$3.48M	4.2%	8
2018 Q2	$51M	Sell	1,973,714 -49,990	-2%	-$1.3M	5.01%	5
2018 Q1	$45.4M	Buy	2,023,704 +1,053,704	+109%	+$25.7M	4.23%	6
2017 Q4	$24.3M	Buy	+970,000	New	+$23.8M	3%	14

Other funds holding FLXN

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Rubric Capital Management (New York)'s FLXN Position: Q4 2019 in Review

Rubric Capital Management (New York) sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2019, closing a stake of 716,473 shares — an estimated $9.82M sold.

Rubric Capital Management (New York) first reported a position in FLXN in Q4 2017 and held it in 8 quarters. The position peaked at $51M in Q2 2018. 133 funds tracked by Wall St. Rank hold FLXN as of Q4 2019.

Rubric Capital Management (New York) reported no remaining Flexion Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
Rubric Capital Management (New York) sold 716,473 Flexion Therapeutics, Inc. shares in Q4 2019, an estimated $9.82M.
Rubric Capital Management (New York) first reported a position in Flexion Therapeutics, Inc. in Q4 2017 and held it in 8 quarters.
Rubric Capital Management (New York)'s Flexion Therapeutics, Inc. position peaked at $51M in Q2 2018.
133 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2019.

Based on Rubric Capital Management (New York)'s 13F filing for Q4 2019, filed 14 Feb 2020.